Cancer

Tuya Pal named Komen Scholar

Susan G. Komen announced on June 23 that Tuya Pal, MD, associate director for Cancer Health Disparities at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Professor of Cancer Research, has been named a Komen Scholar.

Study shows benefit of scheduling lung screens with mammograms

Women who are longtime smokers could potentially save their lives by undergoing lung screens on the same day they schedule mammograms, according to a study by Vanderbilt researchers published in the Journal of Medical Screening.

Treating metastatic prostate cancer

An indirect comparative effectiveness study using published data suggests that the targeted therapy olaparib should be re-evaluated for treating metastatic prostate cancer.

Vanderbilt-Ingram Cancer Center calls for action to get cancer-preventing HPV vaccination back on track

A significant reduction in annual well visits and immunizations during the COVID-19 pandemic has led to a vaccination gap among U.S. children and adolescents, especially with the human papillomavirus (HPV) vaccine for cancer prevention.

Vanderbilt researchers present new data on clinical trials at ASCO 2021

Vanderbilt-Ingram Cancer Center researchers will present data on clinical trials involving targeted therapies, immunotherapies and drug combination synergies at the 2021 American Society of Clinical Oncology Annual Meeting, June 4-8. The meeting is a virtual event this year.

Analysis reveals macrophages associated with kidney cancer recurrence

A white blood cell, the TREM2/APOE/C1Q-positive macrophage, has been identified as a potential biomarker to predict recurrence of the most common type of kidney cancer and as a possible target for drug development.

1 17 18 19 20 21 65